Precision medicine: Ray of hope in overcoming cancer multidrug resistance

Pankaj Musyuni1, Jing Bai2, Afsana Sheikh3

  • 1Centre for Advanced Formulation and Technology (CAFT), Delhi Pharmaceutical Sciences and Research University, Pushp Vihar, Govt. of NCT of Delhi, New Delhi 110017, India.

Insights

Multi-drug resistance (MDR) in cancer therapy leads to treatment failure. Precision medicine offers a targeted approach to overcome MDR by tailoring treatments to individual tumor molecular profiles, improving outcomes.

Area of Science:

  • Oncology
  • Genomics
  • Pharmacology

Background:

  • Multi-drug resistance (MDR) is a primary cause of chemotherapy failure.
  • Tumor microenvironment, genetic alterations, cellular changes, and tumor heterogeneity contribute to MDR.
  • Understanding the human genome is crucial for developing targeted cancer therapies.

Purpose of the Study:

  • To discuss the causes of MDR in cancer.
  • To highlight the role of precision medicine in overcoming MDR.
  • To review the limitations and future prospects of precision medicine in oncology.

Main Methods:

  • Review of current literature on MDR and precision medicine.
  • Analysis of molecular mechanisms underlying tumor resistance.
  • Exploration of precision medicine strategies in oncology.

Main Results:

  • Precision medicine enables therapy design based on individual molecular alterations and tumor environments.
  • This approach facilitates early detection, targeted treatment, and improved patient survival.
  • Precision medicine can reduce the toxicity associated with conventional chemotherapy.

Conclusions:

  • Precision medicine represents a revolutionary approach to cancer therapy, particularly in overcoming MDR.
  • Further research is needed to address limitations and fully realize the potential of precision medicine.
  • Personalized therapeutic strategies hold significant promise for improving cancer treatment efficacy and patient care.

Related Concept Videos

Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.0K
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.8K
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.9K
Cancer Stem Cells and Tumor Maintenance02:40

Cancer Stem Cells and Tumor Maintenance

Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
5.0K
Cancer02:18

Cancer

Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
49.2K